Coverage and Compliance of Human Papillomavirus Vaccines in Paris: Demonstration of Low Compliance With Non-School-Based Approaches
Authors:
- Roman RouzierRRRoman Rouzier
- Jean-Pierre GiordanellaJGJean-Pierre Giordanella
- 1 September 2010
- journal article
- Published by Elsevier in Journal of Adolescent Health
- Vol. 47 (3) , 237-241
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 surveyEuropean Journal of Cancer, 2009
- Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South AustraliaAustralian and New Zealand Journal of Public Health, 2009
- Prevention of Human Papillomavirus Infections and Associated Diseases by Vaccination: A New Hope for Global Public HealthPublic Health Genomics, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008Vaccine, 2008
- Modeling Cervical Cancer Prevention in Developed CountriesVaccine, 2008
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine, 2008
- Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort studyBMJ, 2008
- Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in FranceInternational Journal of Technology Assessment in Health Care, 2008
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsNew England Journal of Medicine, 2007